Company Profile* About the Company Today’s Abdi Ibrahim Shareholders: Barut and Esirtgen Families Abdi Ibrahim Tower: Istanbul, Turkey Production and R&D: Esenyurt, Istanbul Turnover: $853 million Export: $27 million Production Capacity: 350 million boxes Product Range: 53% original pharmaceuticals 47% generic pharmaceuticals Licensors: ~ 30 international companies Employees: ~ 3,300 Today’s Abdi Ibrahim www.abdiibrahim.com.tr * As of December 2011

Vision Mission About the Company To be a well-respected, widely preferred global player that strives to grow more rapidly than the respective pharmaceutical market Mission To produce and supply healthcare products through a pioneering and innovative approach, for the benefit of medicine and humanity www.abdiibrahim.com.tr

A Journey of 100 Years to the Summit About the Company A Journey of 100 Years to the Summit Istanbul Istanbul Algeria 1912 - 1940 1941 - 1999 1999 - 2012 The business started in 1912 with a small pharmacy in Istanbul In 1940, the number of drugs produced at the Abdi Ibrahim Laboratory reached 80 The foundations of the production facilities were laid in 1994 In 1999, international expansion started with the first venture into Algeria Portfolio: 150 brands, more than 250 products, close to 30 licensors, exports to more than 20 countries EU GMP approved manufacturing facility and first accredited R&D www.abdiibrahim.com.tr

Industry Leader for 9 Years Turnover — Consolidated Turnover (Millon $) Turnover — Consolidated Turnover (TL) * As of December 2011 www.abdiibrahim.com.tr

Domestic Sales Development Industry Leader Domestic Sales Development Turnover Development (TL) Turnover Development ($ mio) Manufacturing (2) Domestic sales (contract man. included) Domestic sales turnover (contract man. included) www.abdiibrahim.com.tr * As of December 2011

Market Share — $ Turnover (2011) Industry Leader Market Share Leader in Turkey Market Share — Units (2011) Market Share — $ Turnover (2011) www.abdiibrahim.com.tr Ref. IMS

Industry Leader Export Development www.abdiibrahim.com.tr

$274 Million Investment (1990-2011) Industry Leader $274 Million Investment (1990-2011) www.abdiibrahim.com.tr Fixed Assets $ million

The Largest Sales and Marketing Team in Turkey (2010 - 2011) Industry Leader Success is a Team Game The Largest Sales and Marketing Team in Turkey (2010 - 2011) Number of employees ~ 3300* * Includes Abdica, Reformed and International Markets www.abdiibrahim.com.tr

First Accredited R&D Center in Turkey Manufacturing Plant Production Capacity: 350 million boxes Production Area: 25,000 sqm Employees: > 500 Adhering to global standards cGMP and cGLP certifications ISO 14001 Environmental Management System Certification OHSAS 18001 Work Safety Certification EU GMP approved facility “Energy-Efficient Industrial Facility” Award in 2007 Modern, efficient and environment-friendly technology 2D Matrix Codes technology in the production line automation system Logistic Center Closed Area: 22,000 sq m Total Palette Capacity: 14,500 With an investment of $35 million, Abdi Ibrahim Logistic Center is equipped with the latest state-of-the-art equipment allowing for faster transport and greater performance with fully automation system First Accredited R&D Center in Turkey Total Closed Area: 13,600 sq m Laboratory: 2,000 sq m Pilot Production Area: 900 sq m Offices: 450 sq m Storage Area: 350 sq m Employees: > 150 High level of success in bioequivalence studies CTD files for Turkey and Europe Accelerated development process for equivalent products Development of value-added products

Abdi Ibrahim Global Global Reach Export to more than 20 Countries Production of Original and Generic Pharmaceuticals Licensing Marketing and Registration www.abdiibrahim.com.tr

Global Licencors www.abdiibrahim.com.tr

List of Countries Aİ Operates Own Markets Third Party Countries (Operation through own organization/reps) Third Party Countries (Operation through distributor) Afghanistan Vietnam Yemen Albania Libya Hong Kong Jordan Russia Turkmenistan Algeria Kazakhstan Azerbaijan Georgia Ukraine Iraq Moldova Kosovo Lebanon Germany France UK Belgium Netherlands Canada Uganda, Sudan, Mauritius www.abdiibrahim.com.tr

Outlicensing Countries ( As of 2012) List of Countries Aİ Operates Outlicensing Countries ( As of 2012) Brazil Venezuella South Africa Tunusia Morocco Austria Spain Switzerland Hungary Bulgaria Croatia GCC www.abdiibrahim.com.tr

100th Year Rational Medicine Usage Campaign Undertaking responsibility on the “Rational Medicine Use” campaign initiated by the World Health Organization for the first time in 1985 and applied by the T.R. Ministry of Health since 1992, Abdi İbrahim aims to contribute to preventing the effects of irrational medicine use on the public health and economy. Transmitting its messages to the public with the collaboration of doctors and pharmacists via visual and printed materials in health institutions within the context of the Rational Medicine Use Campaign, Abdi İbrahim also aims to contribute to preventing the waste of resources and establishment of a healthier society by reaching a broader audience via TV ads, radio spots and magazine advertisements. Van Gogh Alive The Turkish pharmaceutical industry leader, Abdi İbrahim, will be celebrating its 100th anniversary with an impressive exhibit never before experienced, in which the works of one of the most famous artists in the world, Vincent Van Gogh, will be presented in a whole new format. This exhibit, where the famous works of Vincent Van Gogh come to life at enormous scale, immersing the audience in a vibrant symphony of light, color & sound reflects Abdi İbrahim’s 100 year vision, by blending art, science and technology with an innovative approach.